Navigation Links
Acclarent, Inc. Closes $26 Million Financing
Date:1/11/2009

MENLO PARK, Calif., Jan. 12 /PRNewswire/ -- Acclarent, Inc., a leading medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat, announced today the closing of a $26 million dollar financing round. Acclarent intends to use the proceeds to continue commercialization of its Balloon Sinuplasty(TM) Technology, as well as on-going investment in product development and clinical studies.

Johnson & Johnson Development Corporation (JJDC) joined existing prominent investors New Enterprise Associates, Inc., Delphi Ventures, Versant Ventures, and Meritech Capital Partners in this financing.

"The addition of JJDC together with the support of our existing financial partners will enable Acclarent to continue executing on our strategy to build the preeminent ENT Company," said Bill Facteau, Acclarent President and CEO.

About Johnson & Johnson Development Corporation. Organized in 1973, Johnson & Johnson Development Corporation is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. For more information, go to http://www.jjdevcorp.com.

About Acclarent, Inc.

Acclarent is a medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat. The company is currently focused on commercializing its Balloon Sinuplasty(TM) Devices, which are flexible, minimally-invasive tools that aid physicians in treating patients suffering from chronic sinusitis.


'/>"/>
SOURCE Acclarent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
2. Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing
3. Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
4. Oaks Development Group Closes on Third San Antonio Project
5. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
6. Morgenthaler Closes Ninth Fund at $400 Million
7. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
8. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
9. Response Biomedical Closes $5.1 Million Financing
10. Blue Cross Blue Shield of Michigan Closes Detroit Operations October 31 Due to Bomb Threat
11. Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology: